Most patients with breast cancer receive curatively intended treatment consisting of surgery and adjuvant chemotherapy (ACT), endocrine therapy, human epidermal growth factor 2 (HER2)-targeted therapy, bisphosphonate or radiotherapy depending on the breast cancer subtype and surgery result [2]. Here, ERBB2 is linked to breast cancer.